IGFBP2 and cervical carcinoma: This was also established in a modified organotypic raft culture containing the HPV16 positive cervical cancer cell line, Caski (S4F and S4G Fig), where IGFBP2, but not IGFBP3, significantly inhibited invasion of the epithelial cells.